BakshiRBischofDKlattJ. Comment on “Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis.”Ann Pharmacother. 2014;48:944.
2.
VenciJVGandhiMA. Ann Pharmacother. 2013;47:1697-1702.
3.
US Food and Drug Administration. FDA drug safety communication: revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod). http://www.fda.gov/Drugs/DrugSafety/ucm303192.htm. Accessed July 24, 2014.
